Physician profile
Adriana Gomez
NPI 1053515619
$1,986.45
in general payments reported to CMS, 2019-2025
14 companies · $336 in 2025
The $336 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $333 · 2020: $206 · 2021: $218 · 2022: $508 · 2023: $169 · 2024: $215 · 2025: $336.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $720.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $720.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $401.16 | 2022-2025 | Freestyle Libre 3, Freestyle Libre 2, Proclaim |
| Novo Nordisk INC | $390.00 | 2020-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $305.38 | 2019-2025 | Farxiga, Airsupra |
| Melinta Therapeutics, LLC | $278.82 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $239.65 | 2019-2023 | Xarelto |
| Ethicon US, LLC | $127.71 | 2022 | |
| Abbvie INC. | $72.25 | 2024 | |
| Merck Sharp & Dohme LLC | $48.54 | 2020-2021 | |
| Gilead Sciences, INC. | $38.55 | 2020-2024 | |
| Medtronic Vascular, INC. | $20.15 | 2020 | |
| Glaxosmithkline, LLC. | $19.44 | 2025 | Shingrix, Arexvy |
| Pfizer INC. | $15.63 | 2022 | |
| Sanofi Pasteur INC. | $15.21 | 2023 | |
| Genentech USA, INC. | $13.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adriana Gomez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.